Bristol Myers Squibb Co., of New York, appointed Elizabeth Mily executive vice president, strategy and business development, effective March 30, 2020.
Leap Therapeutics Inc., of Cambridge, Mass., appointed Douglas E. Onsi president and CEO, while maintaining his current role as chief financial officer. It also named Cynthia Sirard chief medical officer and Mark O’Mahony chief manufacturing officer.
Orchard Therapeutics Ltd., of London, appointed Bobby Gaspar CEO and Frank Thomas president in addition to his roles as chief operating officer and chief financial officer.
Sensei Biotherapeutics Inc., of Gaithersburg, Md., appointed Robert Pierce chief scientific officer.
Sumitomo Dainippon Pharma Co. Ltd., of Osaka, Japan, appointed Koichi Kozuki executive officer, drug development division; deputy executive director, corporate regulatory compliance and quality assurance division; and deputy head of Japan business unit. It also named Yutaka Nishihara senior director, analytical research and development laboratories. Both appointments are effective April 1, 2020.